Blog

News and articles

iQemo: Enabling Safe Management of Anaphylaxis and Hypersensitivity Reactions in SACT

Anaphylaxis and hypersensitivity reactions remain one of the most critical safety challenges in SACT delivery. This article explores how iQemo supports clinical teams in aligning with the latest UK SACT Board guidance through structured documentation, real-time alerts, and workflow visibility. Discover how these features help oncology teams strengthen patient safety from prescribing to administration

Read moreSign-up to the newsletter

BMI Healthcare innovates in cancer services technology

BMI Healthcare, working with iQ HealthTech, has been shortlisted as a finalist in the IT Innovator of the Year category of this year’s HealthInvestor Awards.

Read more

BMI launches rollout of iQemo cancer e-prescribing system

BMI Healthcare will install iQemo, supplied by iQ HealthTech, at all 30 of its hospitals.

Read more

Healthcare at Home sign a 10-year contract with iQ HealthTech

iQ HealthTech have signed a 10 year contract with Healthcare at Home to supply iQemo as their chosen electronic chemotherapy prescribing system.

Read more

We’re working on an innovative future for healthcare technology

Sign up to our newsletter and stay updated with industry-leading advice, insight and more…

Thank you! Your submission has been received!
Sorry, something went wrong while submitting the form.